NDC 51079-802-17
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51079-802
- Requested NDC
- 51079-802-17
- Package NDCs from labels
- 51079-802-17
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2012-07-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51079-802-01 | EA - Each | 51079-802 | 465a2e24-5d65-442d-aef1-4340a6b6fc31 | 1 | 2012-07-24 |
| 51079-802-17 | EA - Each | 51079-802 | 095ca2f0-a6cf-451a-a46a-bb843f581bf1 | 1 | 2012-07-24 |
| 51079-802-19 | EA - Each | 51079-802 | bff227b6-937d-4bea-a583-aa9bae604524 | 1 | 2012-07-24 |
| 51079-802-20 | EA - Each | 51079-802 | c9b9f996-cd45-4526-b1e4-7943f80cfa4c | 1 | 2012-07-24 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Metoprolol Tartrate | METOPROLOL TARTRATE | PD-Rx Pharmaceuticals, Inc. | cbcec1e7-7eac-456e-a253-aaf6761b4883 | 2026-08-11 | Warnings, Adverse reactions | ANDA076704 |
| Metoprolol Tartrate | METOPROLOL TARTRATE | Cardinal Health 107, LLC | 6399f2c3-7799-4f8b-b8b7-8d2137b1f852 | 2026-07-28 | Warnings, Adverse reactions | ANDA076704 |
| Metoprolol Tartrate | METOPROLOL TARTRATE | Cardinal Health 107, LLC | 0ccb9d3c-3f9a-486d-9b27-dc6f3ef6f4ed | 2026-07-10 | Warnings, Adverse reactions | ANDA076704 |
| Metoprolol Tartrate | METOPROLOL TARTRATE | Safecor Health, LLC | 63d45147-9b37-40e2-9619-cd1a3e77ff31 | 2026-07-10 | Warnings, Adverse reactions | ANDA076704 |
| Metoprolol Tartrate | METOPROLOL TARTRATE | PD-Rx Pharmaceuticals, Inc. | ab44f4c5-9497-4c92-8545-e4718ddb8f08 | 2026-05-21 | Warnings, Adverse reactions | ANDA076704 |
| Metoprolol Tartrate | METOPROLOL TARTRATE | Mylan Institutional Inc. | 961248d5-d53c-408d-8f8f-d31885054f96 | 2025-07-22 | Warnings, Adverse reactions | ANDA076704 |
| Metoprolol Tartrate | METOPROLOL TARTRATE | Golden State Medical Supply, Inc. | bec7ccad-00ad-4a3b-e053-2995a90ae3d8 | 2024-03-18 | Warnings, Adverse reactions | ANDA076704 |
| Metoprolol Tartrate | METOPROLOL TARTRATE | Mylan Pharmaceuticals Inc. | 809c6386-0039-42ff-a03e-e42733e229b8 | 2024-01-31 | Warnings, Adverse reactions | ANDA076704 |
| Metoprolol Tartrate | METOPROLOL TARTRATE | Aphena Pharma Solutions - Tennessee, LLC | ea141b60-b08e-4f0f-9f29-cd765f4d7ca6 | 2022-03-10 | Warnings, Adverse reactions | ANDA076704 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.